Over 3 million people in the US suffer from chronic fatigue syndrome (CFS). This is a complex condition characterized by extreme and persistent fatigue. Neither sleep nor rest has been shown to relieve fatigue. Among the many unknowns associated with CFS, there are ways to accurately diagnose the condition.
Cornell University scientists hope to change that. Newly published research in peer-reviewed journals Proceedings of the National Academy of Sciences We will explain the “specific steps” towards developing diagnostic tests.
Diagnosis of chronic fatigue syndrome
Currently, there are no diagnostic tools for CFS. This is also known as muscular encephalomyelitis. Instead, doctors rely on a wide range of patient symptoms, including fatigue, dizziness, and brain fog, in parallel with long and laborious efforts to eliminate other potential causes of these conditions.
Its key is retained in RNA, an important component of human cells that carry commands from DNA to other proteins in the body. When a cell dies, it leaves a genetic record of the RNA released into the bloodstream, revealing changes that occur over a lifetime. Several mechanisms contribute to the release of RNA from cells into the bloodstream, including normal cell death, physical stress, and cell-to-cell communication.
“Outside the cell, these circulating RNA molecules are called cell-free RNAs (CFRNAs). These CFRNA molecules reflect the dynamics of gene expression at key moments of cell turnover or signaling, making them ideal biomarkers for studying complex diseases.
“By measuring the RNA within a cell at a specific time point, we understand which genes are actively expressed depending on the current cellular environment,” adds Gardella.
read more: What do the results of your blood test mean?
Machine Learning and CFRNA
Gardella's team created a machine learning model that can be sieved via CFRNA to identify biomarkers or molecular fingerprints associated with CFS.
“ME/CFS affects many different parts of the body,” said Maureen Hanson, director of the Cornell Center for Protecting Neuroimmune Diseases in a news release. “Nervous system, immune system, [and] Cardiovascular system. Analyzing the plasma gives you access to what's happening in these different parts. ”
The researchers collected blood samples from two groups participating in the study. It is a group diagnosed with CFS and a healthy but sedentary group. People with CFS usually have limited levels of daily activity, so we compare them to sedentary people who allow control of differences in physical activity.
“When comparing them to people with normal levels of activity, changes in CFRNA may reflect differences in body conditioning rather than the true biological effects caused by the disease itself,” Gardella says.
The sampled blood was spin-down using a centrifuge, separating and separating its components. The properties of the RNA molecule were then genetically sequenced to learn the genes of the body that encoded CFRNA.
“Essentially, these computer algorithms “learn” which genes best separate groups and allow new samples to be classified based on their CFRNA expression profile,” Gardella says.
Better diagnostic tools for the future
The researchers collected over 700 RNA transcripts from two groups. All of these were categorized machine learning tools to develop a classification tool that could identify signs of immune stress and other factors observed in CFS patients. We then mapped RNA molecules to show that there are six cell types unique to CFS patients.
“If there are unbalanced signals from a particular cell type, this suggests that there is a fundamental dysregulation of these cells in the disease,” Gardella says.
This test was 77% accurate to detect CFS using these metrics, but this rate is not high enough to be considered a reliable diagnostic tool.
However, it represents important advances in the field of chronic disease diagnosis.
“For clinical use, testing is most useful with accuracy above 90%. However, given the complexity of ME/CFS and relatively small sample size, this model is a promising start to non-invasive testing,” Gardella said.
Furthermore, researchers want to assess how CFRNA changes at different stages of CFS symptoms, as after intense exercise. Patients with CFS may feel that after physical exercise, healthy individuals may be prevented from being asked.
“In the end, we hope that this work will not only contribute to both reliable diagnostic tools and a deeper understanding of ME/CFS, but will continue to bring about an understanding of the biological problems that will bring about the living experiences of these patients,” says Gardella.
read more: Here's what we know about chronic fatigue syndrome if there are no known causes or treatments
article sauce
The authors at DiscoverMagazine.com use peer-reviewed research and high-quality sources in their articles, while editors review scientific accuracy and editing standards. Check out the sources used below in this article.
